95 related articles for article (PubMed ID: 20650201)
1. The stem-cell test: an in vitro assay for teratogenic potential. Results of a blind trial with 25 compounds.
Newall DR; Beedles KE
Toxicol In Vitro; 1996 Apr; 10(2):229-40. PubMed ID: 20650201
[TBL] [Abstract][Full Text] [Related]
2. The stem-cell test-A novel in vitro assay for teratogenic potential.
Newall DR; Beedles KE
Toxicol In Vitro; 1994 Aug; 8(4):697-701. PubMed ID: 20692990
[TBL] [Abstract][Full Text] [Related]
3. An in vitro embryotoxicity assay based on the disturbance of the differentiation of murine embryonic stem cells into endothelial cells. II. Testing of compounds.
Festag M; Viertel B; Steinberg P; Sehner C
Toxicol In Vitro; 2007 Dec; 21(8):1631-40. PubMed ID: 17719739
[TBL] [Abstract][Full Text] [Related]
4. Prevalidation of the Embryonic Stem Cell Test (EST)-A New In Vitro Embryotoxicity Test.
Scholz G; Genschow E; Pohl I; Bremer S; Paparella M; Raabe H; Southee J; Spielmann H
Toxicol In Vitro; 1999; 13(4-5):675-81. PubMed ID: 20654533
[TBL] [Abstract][Full Text] [Related]
5. The regulation of embryonic stem cell differentiation by leukaemia inhibitory factor (LIF).
Murray P; Edgar D
Differentiation; 2001 Oct; 68(4-5):227-34. PubMed ID: 11776475
[TBL] [Abstract][Full Text] [Related]
6. In vitro micromass teratogen test: Interpretation of results from a blind trial of 25 compounds using three separate criteria.
Parsons JF; Rockley J; Richold M
Toxicol In Vitro; 1990; 4(4-5):609-11. PubMed ID: 20702239
[TBL] [Abstract][Full Text] [Related]
7. Paracrine induction of stem cell renewal by LIF-deficient cells: a new ES cell regulatory pathway.
Dani C; Chambers I; Johnstone S; Robertson M; Ebrahimi B; Saito M; Taga T; Li M; Burdon T; Nichols J; Smith A
Dev Biol; 1998 Nov; 203(1):149-62. PubMed ID: 9806780
[TBL] [Abstract][Full Text] [Related]
8. Establishment of a molecular embryonic stem cell developmental toxicity assay.
Panzica-Kelly JM; Brannen KC; Ma Y; Zhang CX; Flint OP; Lehman-McKeeman LD; Augustine-Rauch KA
Toxicol Sci; 2013 Feb; 131(2):447-57. PubMed ID: 23042729
[TBL] [Abstract][Full Text] [Related]
9. In vitro micromass teratogen test: Results from a blind trial of 25 compounds.
Uphill PF; Wilkins SR; Allen JA
Toxicol In Vitro; 1990; 4(4-5):623-6. PubMed ID: 20702245
[TBL] [Abstract][Full Text] [Related]
10. Individual and combined developmental toxicity assessment of bisphenol A and genistein using the embryonic stem cell test in vitro.
Kong D; Xing L; Liu R; Jiang J; Wang W; Shang L; Wei X; Hao W
Food Chem Toxicol; 2013 Oct; 60():497-505. PubMed ID: 23948354
[TBL] [Abstract][Full Text] [Related]
11. [Study on growth and differentiation of ES cells transfected with LIF gene].
Du XX; Shi WK
Shi Yan Sheng Wu Xue Bao; 1996 Dec; 29(4):413-27. PubMed ID: 9772686
[TBL] [Abstract][Full Text] [Related]
12. Development of prediction models for three in vitro embryotoxicity tests in an ECVAM validation study.
Genschow E; Scholz G; Brown N; Piersma A; Brady M; Clemann N; Huuskonen H; Paillard F; Bremer S; Becker K; Spielmann H
In Vitr Mol Toxicol; 2000; 13(1):51-66. PubMed ID: 10900407
[TBL] [Abstract][Full Text] [Related]
13. The potential usefulness of a differentiating teratocarcinoma cell line in in vitro toxicity testing.
Hulme LM; Atkinson KA; Clothier RH; Balls M
Toxicol In Vitro; 1990; 4(4-5):589-92. PubMed ID: 20702235
[TBL] [Abstract][Full Text] [Related]
14. [Directional development and differentiation of mouse embryonic stem cells into hepatocytes in vitro].
Hu AB; Cai JY; Zheng QC; He XQ; Pan YL
Zhonghua Yi Xue Za Zhi; 2003 Sep; 83(18):1592-6. PubMed ID: 14642116
[TBL] [Abstract][Full Text] [Related]
15. Improvement of an in vitro stem cell assay for developmental toxicity: the use of molecular endpoints in the embryonic stem cell test.
Seiler A; Visan A; Buesen R; Genschow E; Spielmann H
Reprod Toxicol; 2004; 18(2):231-40. PubMed ID: 15019721
[TBL] [Abstract][Full Text] [Related]
16. The ECVAM international validation study on in vitro embryotoxicity tests: results of the definitive phase and evaluation of prediction models. European Centre for the Validation of Alternative Methods.
Genschow E; Spielmann H; Scholz G; Seiler A; Brown N; Piersma A; Brady M; Clemann N; Huuskonen H; Paillard F; Bremer S; Becker K
Altern Lab Anim; 2002; 30(2):151-76. PubMed ID: 11971753
[TBL] [Abstract][Full Text] [Related]
17. CD9 is associated with leukemia inhibitory factor-mediated maintenance of embryonic stem cells.
Oka M; Tagoku K; Russell TL; Nakano Y; Hamazaki T; Meyer EM; Yokota T; Terada N
Mol Biol Cell; 2002 Apr; 13(4):1274-81. PubMed ID: 11950938
[TBL] [Abstract][Full Text] [Related]
18. Effect of leukemia inhibitory factor (LIF) on the quality of in vitro produced mouse blastocysts and subsequent derivation of embryonic stem (ES) cells.
Rungsiwiwut R; Rungarunlert S; Numchaisrika P; Pruksananonda K; Techakumphu M; Virutamasen P
J Med Assoc Thai; 2008 May; 91(5):608-14. PubMed ID: 18672620
[TBL] [Abstract][Full Text] [Related]
19. Hepatic differentiation from embryonic stem cells in vitro.
Hu A; Cai J; Zheng Q; He X; Pan Y; Li L
Chin Med J (Engl); 2003 Dec; 116(12):1893-7. PubMed ID: 14687480
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation states of STAT3 and ERKs in mouse embryonic stem cells.
Miyazu S; Furuno T; Nakanishi M
Cell Biol Int; 2010 Mar; 34(5):485-92. PubMed ID: 20136637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
